Ariad Pharmaceuticals (ARIA): Today's Featured Health Care Laggard
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
(
) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.4%. By the end of trading, Ariad Pharmaceuticals fell $0.65 (-3.2%) to $19.37 on light volume. Throughout the day, 1,644,441 shares of Ariad Pharmaceuticals exchanged hands as compared to its average daily volume of 2,695,100 shares. The stock ranged in price between $19.25-$20.11 after having opened the day at $20.00 as compared to the previous trading day's close of $20.02. Other companies within the Health Care sector that declined today were:
(
), down 34.6%,
(
), down 23.9%,
(
), down 17.1% and
Senesco Technologies
(
SNTI
), down 12.7%.
ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. Ariad Pharmaceuticals has a market cap of $3.7 billion and is part of the drugs industry. Shares are up 4.3% year to date as of the close of trading on Friday. Currently there are 14 analysts that rate Ariad Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold.
TheStreet Ratings rates
Ariad Pharmaceuticals
as a
. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.
- You can view the full Ariad Pharmaceuticals Ratings Report.
On the positive front,
(
), up 51.2%,
(
), up 21.3%,
Chelsea Therapeutics International
(
), up 16.0% and
(
), up 13.6% , were all gainers within the health care sector with
(
) being today's featured health care sector leader.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
Health Care Select Sector SPDR
(
) while those bearish on the health care sector could consider
ProShares Ultra Short Health Care
(
).
- Find other investment ideas from our top rated ETFs lists.
null